Verrica Pharmaceuticals Inc. Increase Decrease In Operating Lease Liability
Verrica Pharmaceuticals Inc. (VRCA) reported Increase Decrease In Operating Lease Liability of -$167.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$84.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$83.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$82.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$79.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for fiscal 2025 was -$315.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for fiscal 2024 was -$322.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for fiscal 2023 was -$291.00K.
- Verrica Pharmaceuticals Inc. increase decrease in operating lease liability for fiscal 2022 was -$264.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$167.00K 10-Q · filed 2026-08-06 | -$249.00K derived: sum of 3 quarters · filed 2026-08-06 | -$328.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$83.00K 10-Q · filed 2026-05-12 | -$165.00K derived: sum of 2 quarters · filed 2026-05-12 | -$244.00K derived: sum of 3 quarters · filed 2026-05-12 | -$322.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$161.00K derived: sum of 2 quarters · filed 2026-03-11 | -$239.00K derived: sum of 3 quarters · filed 2026-08-06 | -$315.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$157.00K derived: sum of 2 quarters · filed 2026-08-06 | -$233.00K 10-Q · filed 2025-11-14 | -$300.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$154.00K 10-Q · filed 2026-08-06 | -$221.00K derived: sum of 3 quarters · filed 2026-08-06 | -$318.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$76.00K 10-Q · filed 2026-05-12 | -$143.00K derived: sum of 2 quarters · filed 2026-05-12 | -$240.00K derived: sum of 3 quarters · filed 2026-05-12 | -$319.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$164.00K derived: sum of 2 quarters · filed 2026-03-11 | -$243.00K derived: sum of 3 quarters · filed 2026-03-11 | -$322.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$176.00K derived: sum of 2 quarters · filed 2025-11-14 | -$255.00K 10-Q · filed 2025-11-14 | -$322.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$158.00K 10-Q · filed 2025-08-12 | -$225.00K derived: sum of 3 quarters · filed 2025-08-12 | -$302.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$79.00K 10-Q · filed 2025-05-13 | -$146.00K derived: sum of 2 quarters · filed 2025-05-13 | -$223.00K derived: sum of 3 quarters · filed 2025-05-13 | -$296.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$144.00K derived: sum of 2 quarters · filed 2025-03-11 | -$217.00K derived: sum of 3 quarters · filed 2025-03-11 | -$291.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$150.00K derived: sum of 2 quarters · filed 2024-11-05 | -$224.00K 10-Q · filed 2024-11-05 | -$294.00K derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$147.00K 10-Q · filed 2024-08-14 | -$217.00K derived: sum of 3 quarters · filed 2024-08-14 | -$285.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$74.00K 10-Q · filed 2024-05-13 | -$144.00K derived: sum of 2 quarters · filed 2024-05-13 | -$212.00K derived: sum of 3 quarters · filed 2024-05-13 | -$278.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$138.00K derived: sum of 2 quarters · filed 2024-02-29 | -$204.00K derived: sum of 3 quarters · filed 2024-02-29 | -$264.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$134.00K derived: sum of 2 quarters · filed 2023-11-09 | -$194.00K 10-Q · filed 2023-11-09 | -$251.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$126.00K 10-Q · filed 2023-08-08 | -$183.00K derived: sum of 3 quarters · filed 2023-08-08 | -$240.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$60.00K 10-Q · filed 2023-05-09 | -$117.00K derived: sum of 2 quarters · filed 2023-05-09 | -$174.00K derived: sum of 3 quarters · filed 2023-05-09 | -$230.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$114.00K derived: sum of 2 quarters · filed 2023-03-06 | -$170.00K derived: sum of 3 quarters · filed 2023-03-06 | -$197.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$113.00K derived: sum of 2 quarters · filed 2022-11-07 | -$140.00K 10-Q · filed 2022-11-07 | -$245.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$83.00K 10-Q · filed 2022-08-11 | -$188.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$27.00K 10-Q · filed 2022-05-09 | -$132.00K derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | -$207.00K 10-K · filed 2022-03-02 | ||
| 2020-09-30 | -$102.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |